Causes and management of postoperative enterocutaneous fistulas.
OBJECTIVE
To identify the causes of postoperative enterocutaneous fistulas and to evaluate the results of conservative and operative treatment including the effectiveness of octreotide in the management of these fistulas.


METHODS
A descriptive study.


METHODS
Department of Surgery, Liaquat University of Medical and Health Sciences, Jamshoro / Hyderabad between January 1997 and December 2001.


METHODS
Forty patients with postoperative fistula were studied. Demographic variables, causes and management outcome was observed and recorded.


RESULTS
There were 25 males and 15 females with 50% of the patients being in age group of 21-30 years. Emergency surgery for typhoid perforation(45%) and intestinal tuberculosis (30%) were the commonest causes. Ileum and jejunum were the commonest sites of fistulation found in 85% cases. Twenty-one patients were started on conservative treatment with spontaneous closure occurring in 15 (71.4%) patients. Nineteen patients were operated within three days of admission due to generalized peritonitis (73.7%) and local intra-abdominal collections (26.3%). Wound infection was the commonest complication in the operative group. The mortality rate in this series was 7.5%. All the deaths occurred following surgery.


CONCLUSIONS
Postoperative enterocutaneous fistula has a high morbidity and a significant mortality. Sepsis in the peritoneal cavity is the major cause of mortality. Conservative treatment has a good outcome for these fistulas. The use of octreotide is highly recommended as it definitely converts high output fistulas to low output fistulas.
Memon
Abdul Sattar
AS
Department of Surgery, Liaquat University of Medical and Health Sciences, Jamshoro, Sindh. asattarmemon@hotmail.com
Siddiqui
Faisal Ghani
FG
D000328:Adult; D017577:Cutaneous Fistula / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007412:Intestinal Fistula / Q000188:drug therapy / Q000209:etiology* / Q000601:surgery; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D017063:Outcome Assessment, Health Care; D011183:Postoperative Complications
D005765:Gastrointestinal Agents; D015282:Octreotide